BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21150923)

  • 1. Gender differences in melanoma survival: female patients have a decreased risk of metastasis.
    Joosse A; de Vries E; Eckel R; Nijsten T; Eggermont AM; Hölzel D; Coebergh JW; Engel J;
    J Invest Dermatol; 2011 Mar; 131(3):719-26. PubMed ID: 21150923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.
    Joosse A; Collette S; Suciu S; Nijsten T; Lejeune F; Kleeberg UR; Coebergh JW; Eggermont AM; de Vries E
    J Clin Oncol; 2012 Jun; 30(18):2240-7. PubMed ID: 22547594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
    Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.
    Joosse A; Collette S; Suciu S; Nijsten T; Patel PM; Keilholz U; Eggermont AM; Coebergh JW; de Vries E
    J Clin Oncol; 2013 Jun; 31(18):2337-46. PubMed ID: 23690423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
    Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
    J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
    Nagaraja V; Eslick GD
    Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
    Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
    Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
    Mervic L; Leiter U; Meier F; Eigentler T; Forschner A; Metzler G; Bartenjev I; Büttner P; Garbe C
    Melanoma Res; 2011 Jun; 21(3):244-52. PubMed ID: 21540649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and survival differences between upper and lower extremity melanomas.
    Egger ME; Tabler BL; Dunki-Jacobs EM; Callender GG; Scoggins CR; Martin RC; Quillo AR; Stromberg AJ; McMasters KM
    Am Surg; 2012 Jul; 78(7):779-87. PubMed ID: 22748538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival.
    Gordon D; Smedby KE; Schultz I; Olsson H; Ingvar C; Hansson J; Gillgren P
    Ann Surg Oncol; 2014 Oct; 21(11):3386-94. PubMed ID: 24866434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin metastases of malignant melanoma: a clinical and prognostic survey.
    Savoia P; Fava P; Nardò T; Osella-Abate S; Quaglino P; Bernengo MG
    Melanoma Res; 2009 Oct; 19(5):321-6. PubMed ID: 19641475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: just a marker of health services accessibility?
    Quintella Mendes GL; Koifman S
    Melanoma Res; 2013 Jun; 23(3):199-205. PubMed ID: 23442344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.